Landmark IOL approval

June 14, 2007

The British intraocular lens (IOL) manufacturer, Rayner Intraocular Lenses, has received pre-market approval (PMA) for its C-flex lens from the FDA making it the first non-US IOL to receive FDA approval in twenty years.

The British intraocular lens (IOL) manufacturer, Rayner Intraocular Lenses, has received pre-market approval (PMA) for its C-flex lens from the FDA making it the first non-US IOL to receive FDA approval in twenty years.

The C-flex injectable acrylic lenses have enhanced square edges to help reduce secondary cataract and the bio-comaptible Rayacryl material has an excellent track record on low affinity for silicone oil, sustained clarity and the absence of glare. Anti-vaulting haptics provide centration and help to prevent rotation and vaulting.

C-flex received CE mark approval in 2003.